Jan. 19, 2007 — Daiichi Sankyo Co., Ltd. and Eli Lilly and Co. have announced completion of patient enrollment in their pivotal Phase III head-to-head clinical study — TRITON TIMI-38 — to evaluate the safety and efficacy of prasugrel compared with clopidogrel (Plavix) in patients with acute coronary syndrome undergoing percutaneous coronary intervention (PCI).

Elliott Antman, M.D., director of the Samuel A. Levine Cardiac Unit at Brigham and Women's Medical Center is the study’s lead investigator and senior investigator in the TIMI Study Group.

Jan. 19, 2007 — A new introducer sheath designed specifically for superficial access procedures has been introduced by Terumo Interventional Systems, a strategic business unit of medical device manufacturer Terumo Medical Corp.

Jan. 18, 2007 - GE and Abbott have entered into a definitive agreement for GE to acquire Abbott's primary in vitro diagnostics businesses and Abbott Point-of-Care diagnostics business (formerly known as i-STAT) for $8.13 billion in cash. Abbott's Molecular Diagnostics and Diabetes Care businesses are not part of the transaction and will remain part of Abbott.

Jan. 15, 2007 — Medtronic, Inc. announced today its launch of a national campaign designed to raise awareness of sudden cardiac arrest (SCA), its risk factors, and the role of implantable cardioverter-defibrillator (ICD) therapy in saving lives. SCA is the one of the nation's leading causes of death -- claiming more lives than breast cancer, lung cancer, and HIV/AIDS combined.

Jan. 11, 2007 — Fujifilm has announced its acquisition of cardiology PACS vendor ProSolv in Indianapolis. The company will now be known as ProSolv CardioVascular, a Fujifilm Company, and will operate as a wholly owned subsidiary, according to a press statement.